XML 61 R46.htm IDEA: XBRL DOCUMENT v3.20.2
Collaborative Arrangement - Additional Information (Detail) - USD ($)
3 Months Ended 12 Months Ended
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2018
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                      
Total revenue $ 22,543,000 $ 26,883,000 $ 22,822,000 $ 22,616,000 $ 30,816,000 $ 24,344,000 $ 22,676,000 $ 22,241,000 $ 94,864,000 $ 100,077,000 $ 81,336,000
Abbott Agreement [Member]                      
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                      
Collaborative arrangement payment received                 45,800,000    
Collaborative arrangement additional potential milestone payments receivable 45,000,000               45,000,000    
Total revenue                 12,000,000.0 13,500,000 4,400,000
Upfront and milestone fee payment included in deferred revenue 15,900,000       17,100,000       15,900,000 17,100,000  
Collaboration revenue recognized included in balance at beginning of period                 5,000,000.0 8,400,000  
Abbott Agreement [Member] | Contract Life to Date [Member]                      
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                      
Total revenue                 29,900,000    
Abbott Agreement [Member] | Upfront Payment [Member]                      
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                      
Collaborative arrangement payment received                     $ 25,000,000
Abbott Agreement [Member] | Milestone Payment [Member]                      
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                      
Collaborative arrangement payment received   $ 10,800,000     $ 10,000,000       10,800,000 $ 10,000,000  
Abbott Agreement [Member] | Clinical Trial Report Milestone [Member] | TRANSCEND Clinical Trial [Member]                      
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                      
Collaborative arrangement additional potential milestone payments receivable 15,000,000               15,000,000    
Abbott Agreement [Member] | PMA Milestone [Member] | TRANSCEND Clinical Trial [Member]                      
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                      
Collaborative arrangement additional potential milestone payments receivable $ 30,000,000               $ 30,000,000